Literature DB >> 1939529

Testicular tumors in congenital adrenal hyperplasia: steroid measurements from adrenal and spermatic veins.

J Blumberg-Tick1, P Boudou, K Nahoul, G Schaison.   

Abstract

The present study reports the case of a 25-yr-old man with congenital adrenal hyperplasia due to 21-hydroxylase deficiency in whom bilateral testicular tumors did not regress after suppressive treatment with dexamethasone. Catheterization of left testicular and adrenal veins confirmed the enzyme deficiency in the gonadal lesions. The presence of specific 11 beta-hydroxylated steroids (11 beta-hydroxyandrostenedione, 21-deoxycortisol, and 21-deoxycorticosterone) in the gonadal vein demonstrated the adrenal nature of the testicular tumor. In addition, catheterization allowed further study of the secretion of mineralocorticoids and androgens in the adrenal venous effluent. Plasma levels of deoxycorticosterone were increased in the peripheral vein and decreased in the adrenal vein, confirming the conversion of progesterone by peripheral 21-hydroxylase activity. Plasma levels of delta 5-3 beta-hydroxysteroids, particularly dehydroepiandrosterone and its sulfate, were very low, suggesting a sustained stimulation of 3 beta-hydroxysteroid dehydrogenase activity. This study documents that in patients with congenital adrenal hyperplasia and bilateral testicular tumors, catheterization of a gonadal vein measuring specific 11 beta-hydroxylated steroids confirms the adrenal nature of the gonadal lesions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939529     DOI: 10.1210/jcem-73-5-1129

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.

Authors:  Krupali Bulsari; Henrik Falhammar
Journal:  Endocrine       Date:  2016-12-07       Impact factor: 3.633

2.  Testis sparing surgery for steroid unresponsive testicular tumors of the congenital adrenal hyperplasia.

Authors:  Tuğrul Tiryaki; Zehra Aycan; Sema Hücümenoğlu; Halil Atayurt
Journal:  Pediatr Surg Int       Date:  2005-10-21       Impact factor: 1.827

3.  Profiles of 21-Carbon Steroids in 21-hydroxylase Deficiency.

Authors:  Adina F Turcu; Juilee Rege; Robert Chomic; Jiayan Liu; Hiromi K Nishimoto; Tobias Else; Andreas G Moraitis; Ganesh S Palapattu; William E Rainey; Richard J Auchus
Journal:  J Clin Endocrinol Metab       Date:  2015-04-07       Impact factor: 5.958

4.  Leydig cell tumor in two brothers with congenital adrenal hyperplasia due to 11-β hydroxylase deficiency: a case report.

Authors:  Pegah Entezari; Abdol Mohammad Kajbafzadeh; Fatemeh Mahjoub; Mohammad Vasei
Journal:  Int Urol Nephrol       Date:  2011-01-23       Impact factor: 2.370

5.  Pituitary gonadal axis and child rate in males with classical 21-hydroxylase deficiency.

Authors:  J Jääskeläinen; O Kiekara; M Hippeläinen; R Voutilainen
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

Review 6.  Bilateral testicular enlargement due to adrenal remnant in a patient with C11 hydroxylase deficiency congenital adrenal hyperplasia.

Authors:  A A M Ghazi; F Hadayegh; G Khakpour; F Azizi; J C Melby
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

7.  Testicular adrenal rest tumours in postpubertal males with congenital adrenal hyperplasia: sonographic and MR features.

Authors:  Nike M M L Stikkelbroeck; Harold M Suliman; Barto J Otten; Ad R M M Hermus; Johan G Blickman; Gerrit J Jager
Journal:  Eur Radiol       Date:  2003-01-18       Impact factor: 5.315

8.  [Bilateral testicular masses in the scope of adrenogenital syndrome].

Authors:  C Helke; M May; S Stolz; M Seehafer; T Erler; B Hoschke
Journal:  Urologe A       Date:  2003-12       Impact factor: 0.639

9.  Testicular adrenal rest tumours in congenital adrenal hyperplasia.

Authors:  H L Claahsen-van der Grinten; A R M M Hermus; B J Otten
Journal:  Int J Pediatr Endocrinol       Date:  2009-02-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.